Zevalin-beam for Aggressive Lymphoma
NCT00491491
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
60
Enrollment
OTHER_GOV
Sponsor class
Conditions
Non-Hodgkin's Lymphoma
Interventions
DRUG:
ibritumomab tiuxetan
PROCEDURE:
BEAM chemotherapy and autologous stem-cell transplantation
Sponsor
Sheba Medical Center
Collaborators
[object Object]
[object Object]
[object Object]